Clinical Trials Browser

Phase 3 × Neurotoxicity Syndromes × Thoracic × Clear all

NCT01882621 2016-06-01

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Neurotoxicity Syndromes